Articles tagged with: ASH 2012 Daily Update
News»

Yesterday was the second day of the 2012 American Society of Hematology (ASH) annual meeting, which is being held in Atlanta.
The day's myeloma-related presentations began in the afternoon with three sessions of oral presentations. Two of the sessions focused on results from clinical trials, most of which studied drugs that are still being developed for the treatment of multiple myeloma. The third session, which focused on the biology of myeloma, ran simultaneously with one of the sessions about clinical trial results.
An update published yesterday evening summarized the results for the …
News»

This year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta, began yesterday and goes through Tuesday.
Today’s myeloma-related presentations began this afternoon with three sessions of oral presentations. Two of the sessions focused on results from clinical trials, most of which studied drugs that are still under development as potential treatments for multiple myeloma. The third session, which focused on the biology of myeloma, ran simultaneously with one of the sessions about clinical trial results.
This article will summarize the first oral session about multiple myeloma treatments, …
News»

Yesterday was the first day of research presentations at this year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta.
Research findings related to multiple myeloma was presented in three different sessions during the day.
Two of the sessions were actually the same general educational session about multiple myeloma, repeated at two different times during the day. The Beacon will cover the presentations given during those sessions in a separate daily update.
The key myeloma-related research presented yesterday, however, was made public during a poster session in the …